Novo’s obesity drug cuts risk of heart disease in study

[ad_1] A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photo Aug 8…

BioNTech reduces drug development spend as COVID vaccine sales plunge

[ad_1] The logo of BioNTech is pictured at Biontech’s research laboratory for individualised vaccines against cancer in Mainz, Germany, July 27, 2023. REUTERS/Wolfgang Rattay/File Photo FRANKFURT, Aug 7 (Reuters) –…

Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market

[ad_1] FRANKFURT, July 29 (Reuters) – Novo Nordisk has launched blockbuster weight-loss drug Wegovy in Germany, its first big European market, hoping Germans will pay hundreds of euros out of…

Aspartame sweetener used in Diet Coke a possible carcinogen, WHO’s cancer research agency to say – sources

[ad_1] LONDON, June 29 (Reuters) – One of the world’s most common artificial sweeteners is set to be declared a possible carcinogen next month by a leading global health body,…

Novo Nordisk to slash US insulin prices, following move by Eli Lilly

[ad_1] March 14 (Reuters) – Novo Nordisk (NOVOb.CO) said on Tuesday it would cut U.S. list prices for several insulin products by up to 75% next year, joining rival Eli…